CardioGenics Holdings Inc
CardioGenics Holdings Inc CGNH Peers
See (CGNH) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CGNH | $0.00 | N/A | 12K | N/A | N/A | N/A |
| LZAGY | $68.56 | +0.10% | 49.5B | 64.07 | $1.07 | +0.75% |
| LZAGF | $672.60 | -0.06% | 47.3B | 62.92 | $10.69 | +0.43% |
| WUXAY | $9.34 | +3.35% | 26.7B | 17.29 | $0.54 | +0.70% |
| WUXIF | $7.34 | N/A | 20.7B | 13.59 | $0.54 | +2.54% |
| BMXMF | $134.25 | +1.18% | 15.8B | 32.82 | $4.09 | +0.69% |
| ERFSF | $64.53 | -1.52% | 11.4B | 27.23 | $2.37 | +1.60% |
| SKHHY | $17.41 | +0.75% | 8.4B | 23.85 | $0.73 | +3.88% |
| SKHCF | $16.39 | +0.68% | 7.9B | 22.45 | $0.73 | +4.28% |
| HNGZY | $4.00 | N/A | 5.1B | 26.67 | $0.15 | +1.99% |
Stock Comparison
CGNH vs LZAGY Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, LZAGY has a market cap of 49.5B. Regarding current trading prices, CGNH is priced at $0.00, while LZAGY trades at $68.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas LZAGY's P/E ratio is 64.07. In terms of profitability, CGNH's ROE is +1.41%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, CGNH is less volatile compared to LZAGY. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs LZAGF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, LZAGF has a market cap of 47.3B. Regarding current trading prices, CGNH is priced at $0.00, while LZAGF trades at $672.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas LZAGF's P/E ratio is 62.92. In terms of profitability, CGNH's ROE is +1.41%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, CGNH is less volatile compared to LZAGF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs WUXAY Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, WUXAY has a market cap of 26.7B. Regarding current trading prices, CGNH is priced at $0.00, while WUXAY trades at $9.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas WUXAY's P/E ratio is 17.29. In terms of profitability, CGNH's ROE is +1.41%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, CGNH is less volatile compared to WUXAY. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs WUXIF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, WUXIF has a market cap of 20.7B. Regarding current trading prices, CGNH is priced at $0.00, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, CGNH's ROE is +1.41%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, CGNH and WUXIF have similar daily volatility (0.00).
CGNH vs BMXMF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, BMXMF has a market cap of 15.8B. Regarding current trading prices, CGNH is priced at $0.00, while BMXMF trades at $134.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas BMXMF's P/E ratio is 32.82. In terms of profitability, CGNH's ROE is +1.41%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, CGNH and BMXMF have similar daily volatility (0.00).
CGNH vs ERFSF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, ERFSF has a market cap of 11.4B. Regarding current trading prices, CGNH is priced at $0.00, while ERFSF trades at $64.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas ERFSF's P/E ratio is 27.23. In terms of profitability, CGNH's ROE is +1.41%, compared to ERFSF's ROE of +0.07%. Regarding short-term risk, CGNH is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs SKHHY Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, SKHHY has a market cap of 8.4B. Regarding current trading prices, CGNH is priced at $0.00, while SKHHY trades at $17.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas SKHHY's P/E ratio is 23.85. In terms of profitability, CGNH's ROE is +1.41%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, CGNH is less volatile compared to SKHHY. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs SKHCF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, SKHCF has a market cap of 7.9B. Regarding current trading prices, CGNH is priced at $0.00, while SKHCF trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas SKHCF's P/E ratio is 22.45. In terms of profitability, CGNH's ROE is +1.41%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, CGNH and SKHCF have similar daily volatility (0.00).
CGNH vs HNGZY Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, HNGZY has a market cap of 5.1B. Regarding current trading prices, CGNH is priced at $0.00, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, CGNH's ROE is +1.41%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, CGNH is less volatile compared to HNGZY. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs DSRLF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, DSRLF has a market cap of 5B. Regarding current trading prices, CGNH is priced at $0.00, while DSRLF trades at $92.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas DSRLF's P/E ratio is 23.73. In terms of profitability, CGNH's ROE is +1.41%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, CGNH is less volatile compared to DSRLF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs VIMGF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, VIMGF has a market cap of 1.8B. Regarding current trading prices, CGNH is priced at $0.00, while VIMGF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas VIMGF's P/E ratio is 70.00. In terms of profitability, CGNH's ROE is +1.41%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, CGNH and VIMGF have similar daily volatility (0.00).
CGNH vs MRCHF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, MRCHF has a market cap of 1.2B. Regarding current trading prices, CGNH is priced at $0.00, while MRCHF trades at $20.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas MRCHF's P/E ratio is 61.62. In terms of profitability, CGNH's ROE is +1.41%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, CGNH is less volatile compared to MRCHF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs IMMVF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, IMMVF has a market cap of 918.2M. Regarding current trading prices, CGNH is priced at $0.00, while IMMVF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas IMMVF's P/E ratio is -13.04. In terms of profitability, CGNH's ROE is +1.41%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, CGNH is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs THOXF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, THOXF has a market cap of 341M. Regarding current trading prices, CGNH is priced at $0.00, while THOXF trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas THOXF's P/E ratio is -37.50. In terms of profitability, CGNH's ROE is +1.41%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, CGNH is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs AMCY Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, CGNH is priced at $0.00, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas AMCY's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to AMCY's ROE of N/A. Regarding short-term risk, CGNH and AMCY have similar daily volatility (0.00).
CGNH vs EDTXF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, EDTXF has a market cap of 170.6M. Regarding current trading prices, CGNH is priced at $0.00, while EDTXF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas EDTXF's P/E ratio is -9.97. In terms of profitability, CGNH's ROE is +1.41%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, CGNH is less volatile compared to EDTXF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs IDGXF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, IDGXF has a market cap of 164.5M. Regarding current trading prices, CGNH is priced at $0.00, while IDGXF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas IDGXF's P/E ratio is 7.07. In terms of profitability, CGNH's ROE is +1.41%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, CGNH and IDGXF have similar daily volatility (0.00).
CGNH vs NNGRF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, CGNH is priced at $0.00, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, CGNH's ROE is +1.41%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, CGNH and NNGRF have similar daily volatility (0.00).
CGNH vs CORBF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, CORBF has a market cap of 133.9M. Regarding current trading prices, CGNH is priced at $0.00, while CORBF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas CORBF's P/E ratio is 3.03. In terms of profitability, CGNH's ROE is +1.41%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, CGNH and CORBF have similar daily volatility (0.00).
CGNH vs DIUXF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, CGNH is priced at $0.00, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, CGNH's ROE is +1.41%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, CGNH and DIUXF have similar daily volatility (0.00).
CGNH vs ANPCF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, ANPCF has a market cap of 100M. Regarding current trading prices, CGNH is priced at $0.00, while ANPCF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas ANPCF's P/E ratio is -3.10. In terms of profitability, CGNH's ROE is +1.41%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, CGNH is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs TIHE Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, CGNH is priced at $0.00, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas TIHE's P/E ratio is 0.32. In terms of profitability, CGNH's ROE is +1.41%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, CGNH and TIHE have similar daily volatility (0.00).
CGNH vs BIOGF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, CGNH is priced at $0.00, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, CGNH's ROE is +1.41%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, CGNH and BIOGF have similar daily volatility (0.00).
CGNH vs PFGTF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, PFGTF has a market cap of 65M. Regarding current trading prices, CGNH is priced at $0.00, while PFGTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas PFGTF's P/E ratio is -4.00. In terms of profitability, CGNH's ROE is +1.41%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, CGNH and PFGTF have similar daily volatility (0.00).
CGNH vs PCNEF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, CGNH is priced at $0.00, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, CGNH's ROE is +1.41%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, CGNH and PCNEF have similar daily volatility (0.00).
CGNH vs SZLSF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, SZLSF has a market cap of 60M. Regarding current trading prices, CGNH is priced at $0.00, while SZLSF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas SZLSF's P/E ratio is -0.42. In terms of profitability, CGNH's ROE is +1.41%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, CGNH and SZLSF have similar daily volatility (0.00).
CGNH vs CLIFF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, CGNH is priced at $0.00, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, CGNH's ROE is +1.41%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, CGNH is less volatile compared to CLIFF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs BIOQ Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, BIOQ has a market cap of 40.2M. Regarding current trading prices, CGNH is priced at $0.00, while BIOQ trades at $45.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas BIOQ's P/E ratio is 15.85. In terms of profitability, CGNH's ROE is +1.41%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, CGNH and BIOQ have similar daily volatility (0.00).
CGNH vs ANPCY Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, ANPCY has a market cap of 33.2M. Regarding current trading prices, CGNH is priced at $0.00, while ANPCY trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas ANPCY's P/E ratio is -1.58. In terms of profitability, CGNH's ROE is +1.41%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, CGNH is less volatile compared to ANPCY. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs SNANF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, SNANF has a market cap of 28.2M. Regarding current trading prices, CGNH is priced at $0.00, while SNANF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas SNANF's P/E ratio is -13.00. In terms of profitability, CGNH's ROE is +1.41%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, CGNH and SNANF have similar daily volatility (0.00).
CGNH vs PCHM Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, PCHM has a market cap of 21.1M. Regarding current trading prices, CGNH is priced at $0.00, while PCHM trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas PCHM's P/E ratio is -0.02. In terms of profitability, CGNH's ROE is +1.41%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, CGNH and PCHM have similar daily volatility (0.00).
CGNH vs VILGF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, CGNH is priced at $0.00, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas VILGF's P/E ratio is -0.30. In terms of profitability, CGNH's ROE is +1.41%, compared to VILGF's ROE of N/A. Regarding short-term risk, CGNH and VILGF have similar daily volatility (0.00).
CGNH vs BMKDF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, BMKDF has a market cap of 19.6M. Regarding current trading prices, CGNH is priced at $0.00, while BMKDF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas BMKDF's P/E ratio is -21.61. In terms of profitability, CGNH's ROE is +1.41%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, CGNH and BMKDF have similar daily volatility (0.00).
CGNH vs MBGNF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, MBGNF has a market cap of 17.3M. Regarding current trading prices, CGNH is priced at $0.00, while MBGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas MBGNF's P/E ratio is -100.00. In terms of profitability, CGNH's ROE is +1.41%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, CGNH is less volatile compared to MBGNF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs LDXHF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, LDXHF has a market cap of 15M. Regarding current trading prices, CGNH is priced at $0.00, while LDXHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas LDXHF's P/E ratio is -2.00. In terms of profitability, CGNH's ROE is +1.41%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, CGNH is less volatile compared to LDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs PMSNF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, PMSNF has a market cap of 14.8M. Regarding current trading prices, CGNH is priced at $0.00, while PMSNF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas PMSNF's P/E ratio is -2.50. In terms of profitability, CGNH's ROE is +1.41%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, CGNH and PMSNF have similar daily volatility (0.00).
CGNH vs ABDXF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, CGNH is priced at $0.00, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, CGNH's ROE is +1.41%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, CGNH and ABDXF have similar daily volatility (0.00).
CGNH vs JMPHF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, JMPHF has a market cap of 13.4M. Regarding current trading prices, CGNH is priced at $0.00, while JMPHF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas JMPHF's P/E ratio is -2.91. In terms of profitability, CGNH's ROE is +1.41%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, CGNH and JMPHF have similar daily volatility (0.00).
CGNH vs IZOZF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, IZOZF has a market cap of 12.4M. Regarding current trading prices, CGNH is priced at $0.00, while IZOZF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas IZOZF's P/E ratio is -6.84. In terms of profitability, CGNH's ROE is +1.41%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, CGNH is less volatile compared to IZOZF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs MXDHF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, CGNH is priced at $0.00, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, CGNH's ROE is +1.41%, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, CGNH and MXDHF have similar daily volatility (0.00).
CGNH vs VRCDF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, VRCDF has a market cap of 7.3M. Regarding current trading prices, CGNH is priced at $0.00, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, CGNH's ROE is +1.41%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, CGNH is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs SQIDF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, CGNH is priced at $0.00, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, CGNH's ROE is +1.41%, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, CGNH is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs TDSGF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, TDSGF has a market cap of 6M. Regarding current trading prices, CGNH is priced at $0.00, while TDSGF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas TDSGF's P/E ratio is -2.01. In terms of profitability, CGNH's ROE is +1.41%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, CGNH and TDSGF have similar daily volatility (0.00).
CGNH vs IBXXF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, IBXXF has a market cap of 4.8M. Regarding current trading prices, CGNH is priced at $0.00, while IBXXF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas IBXXF's P/E ratio is -0.80. In terms of profitability, CGNH's ROE is +1.41%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, CGNH is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs ICBU Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, ICBU has a market cap of 4.3M. Regarding current trading prices, CGNH is priced at $0.00, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas ICBU's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, CGNH is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs SLDX Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, SLDX has a market cap of 4.2M. Regarding current trading prices, CGNH is priced at $0.00, while SLDX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas SLDX's P/E ratio is -0.01. In terms of profitability, CGNH's ROE is +1.41%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, CGNH and SLDX have similar daily volatility (0.00).
CGNH vs IDXG Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, IDXG has a market cap of 3.7M. Regarding current trading prices, CGNH is priced at $0.00, while IDXG trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas IDXG's P/E ratio is 3.00. In terms of profitability, CGNH's ROE is +1.41%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, CGNH is less volatile compared to IDXG. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs GNTLF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, GNTLF has a market cap of 3.7M. Regarding current trading prices, CGNH is priced at $0.00, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, CGNH's ROE is +1.41%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, CGNH and GNTLF have similar daily volatility (0.00).
CGNH vs AVCRF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, AVCRF has a market cap of 2.6M. Regarding current trading prices, CGNH is priced at $0.00, while AVCRF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas AVCRF's P/E ratio is -2.60. In terms of profitability, CGNH's ROE is +1.41%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, CGNH is less volatile compared to AVCRF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs IDTA Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, IDTA has a market cap of 1.7M. Regarding current trading prices, CGNH is priced at $0.00, while IDTA trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas IDTA's P/E ratio is 4.15. In terms of profitability, CGNH's ROE is +1.41%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, CGNH and IDTA have similar daily volatility (0.00).
CGNH vs IVRO Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, IVRO has a market cap of 1.6M. Regarding current trading prices, CGNH is priced at $0.00, while IVRO trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas IVRO's P/E ratio is -0.87. In terms of profitability, CGNH's ROE is +1.41%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, CGNH is less volatile compared to IVRO. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs NSTM Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, NSTM has a market cap of 1.2M. Regarding current trading prices, CGNH is priced at $0.00, while NSTM trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas NSTM's P/E ratio is -0.42. In terms of profitability, CGNH's ROE is +1.41%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, CGNH is less volatile compared to NSTM. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs DIGP Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, CGNH is priced at $0.00, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas DIGP's P/E ratio is -1.04. In terms of profitability, CGNH's ROE is +1.41%, compared to DIGP's ROE of +3.08%. Regarding short-term risk, CGNH is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs SCRSF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, SCRSF has a market cap of 903K. Regarding current trading prices, CGNH is priced at $0.00, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, CGNH's ROE is +1.41%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, CGNH and SCRSF have similar daily volatility (0.00).
CGNH vs RSHN Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, RSHN has a market cap of 817.5K. Regarding current trading prices, CGNH is priced at $0.00, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas RSHN's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, CGNH and RSHN have similar daily volatility (0.00).
CGNH vs EPGNF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, EPGNF has a market cap of 692.4K. Regarding current trading prices, CGNH is priced at $0.00, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, CGNH's ROE is +1.41%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, CGNH is less volatile compared to EPGNF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs TOMDF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, TOMDF has a market cap of 140.8K. Regarding current trading prices, CGNH is priced at $0.00, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas TOMDF's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, CGNH is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs NVTAQ Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, CGNH is priced at $0.00, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, CGNH's ROE is +1.41%, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, CGNH is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs ARYC Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, CGNH is priced at $0.00, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas ARYC's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, CGNH is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs HCLC Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, CGNH is priced at $0.00, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas HCLC's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, CGNH and HCLC have similar daily volatility (0.00).
CGNH vs OPGX Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, OPGX has a market cap of 55K. Regarding current trading prices, CGNH is priced at $0.00, while OPGX trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas OPGX's P/E ratio is -0.17. In terms of profitability, CGNH's ROE is +1.41%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, CGNH is less volatile compared to OPGX. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs MEDVF Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, MEDVF has a market cap of 54K. Regarding current trading prices, CGNH is priced at $0.00, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, CGNH's ROE is +1.41%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, CGNH and MEDVF have similar daily volatility (0.00).
CGNH vs RNVA Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, RNVA has a market cap of 43.1K. Regarding current trading prices, CGNH is priced at $0.00, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas RNVA's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, CGNH and RNVA have similar daily volatility (0.00).
CGNH vs CHHL Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, CGNH is priced at $0.00, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas CHHL's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, CGNH is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs MEDD Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, CGNH is priced at $0.00, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas MEDD's P/E ratio is -0.01. In terms of profitability, CGNH's ROE is +1.41%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, CGNH and MEDD have similar daily volatility (0.00).
CGNH vs IHTI Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, IHTI has a market cap of 28.5K. Regarding current trading prices, CGNH is priced at $0.00, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas IHTI's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, CGNH is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs ABMC Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, CGNH is priced at $0.00, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas ABMC's P/E ratio is 0.01. In terms of profitability, CGNH's ROE is +1.41%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, CGNH and ABMC have similar daily volatility (0.00).
CGNH vs CYPS Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, CYPS has a market cap of 4.1K. Regarding current trading prices, CGNH is priced at $0.00, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas CYPS's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to CYPS's ROE of N/A. Regarding short-term risk, CGNH is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs DMTKQ Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, DMTKQ has a market cap of 3.5K. Regarding current trading prices, CGNH is priced at $0.00, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, CGNH is less volatile compared to DMTKQ. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs GWHP Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, CGNH is priced at $0.00, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas GWHP's P/E ratio is -0.00. In terms of profitability, CGNH's ROE is +1.41%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, CGNH is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for CGNH.
CGNH vs ROSGQ Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, CGNH is priced at $0.00, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, CGNH and ROSGQ have similar daily volatility (0.00).
CGNH vs BIOCQ Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, CGNH is priced at $0.00, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas BIOCQ's P/E ratio is -0.00. In terms of profitability, CGNH's ROE is +1.41%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, CGNH and BIOCQ have similar daily volatility (0.00).
CGNH vs HTGMQ Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, CGNH is priced at $0.00, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, CGNH and HTGMQ have similar daily volatility (0.00).
CGNH vs RGDXQ Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, RGDXQ has a market cap of 39. Regarding current trading prices, CGNH is priced at $0.00, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, CGNH and RGDXQ have similar daily volatility (0.00).
CGNH vs MRPS Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, MRPS has a market cap of 0. Regarding current trading prices, CGNH is priced at $0.00, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas MRPS's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to MRPS's ROE of N/A. Regarding short-term risk, CGNH and MRPS have similar daily volatility (0.00).
CGNH vs BGNX Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, BGNX has a market cap of 0. Regarding current trading prices, CGNH is priced at $0.00, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas BGNX's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to BGNX's ROE of N/A. Regarding short-term risk, CGNH and BGNX have similar daily volatility (0.00).
CGNH vs AGHC Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, AGHC has a market cap of 0. Regarding current trading prices, CGNH is priced at $0.00, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas AGHC's P/E ratio is N/A. In terms of profitability, CGNH's ROE is +1.41%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, CGNH and AGHC have similar daily volatility (0.00).
CGNH vs EPGNY Comparison
CGNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CGNH stands at 12K. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, CGNH is priced at $0.00, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CGNH currently has a P/E ratio of N/A, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, CGNH's ROE is +1.41%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, CGNH and EPGNY have similar daily volatility (0.00).